GlassScriptPhysician profile
Jeffrey Pokorny
NPI 1275506362
$1,188.80
in general payments reported to CMS, 2019-2025
16 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $195 · 2021: $97.45 · 2022: $207 · 2023: $216 · 2024: $209 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $277.95 | 2019-2024 | Xiaflex |
| Galderma Laboratories, L.P. | $229.56 | 2020-2024 | |
| Organogenesis INC. | $131.60 | 2021-2024 | Puraply |
| Kowa Pharmaceuticals America, INC. | $97.03 | 2022-2023 | Seglentis |
| Revance Therapeutics, INC. | $93.66 | 2025 | Daxxify |
| Sonex Health, INC. | $57.75 | 2023-2025 | Sx-One Microknife |
| Endo USA, INC. | $50.81 | 2024-2025 | Xiaflex |
| Davol INC. | $42.92 | 2022 | |
| Tela Bio, INC. | $34.21 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $31.80 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Lifenet Health | $29.32 | 2024 | Theragenesis Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $28.03 | 2022 | |
| Merz North America, INC. | $25.87 | 2023 | Xeomin |
| Bioventus LLC | $24.87 | 2022 | |
| Solventum Corporation | $21.59 | 2025 | Activ.A.C. |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $11.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pokorny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.